Ivermectin Inhibits Stress Granule Clearance by Blocking the De Novo Synthesis of Hsp70 in Neuroblastoma (2026)

Peer-Reviewed Study · Chu S; Anim EP; Salehi-Tabar R; White JH; Stochaj U · September 2026

Chu S et al., 2026-09: Neuroblastoma and cervical carcinoma cell study reporting that ivermectin delays stress-granule disassembly by blocking de novo Hsp70 synthesis, adding a proteostasis mechanism alongside its nuclear-transport effects.

The anti-parasitic drug ivermectin inhibits nuclear trafficking and has potential anti-cancer activities. However, the molecular pathways that promote ivermectin's therapeutic actions are poorly understood.

n/a (HTML full text)

Chu S et al., 2026-09: Neuroblastoma and cervical carcinoma cell study reporting that ivermectin delays stress-granule disassembly by blocking de novo Hsp70 synthesis, adding a proteostasis mechanism alongside its nuclear-transport effects. Study type: human neuroblastoma and cervical carcinoma cell lines, in vitro. N: n/a. Country: Canada (McGill University, Montreal). Dose: not stated in the abstract. Declared COI: 'The authors declare no conflicts of interest.' Comparator: untreated stressed cells. Adds Hsp70 to the 'other targets' list in C8. Study type: lab.